Phase 2a Study of the Efficacy and Safety of TRX-100 in a Human Influenza A Challenge Model
Study sponsor: Traws Pharma, Inc. · TRAW
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2026-11Estimated
Enrollment · participants165Estimated
Source updated2026-03-31Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.